Hofseth BioCare ASA (OSL: HBC)
2.020
-0.030 (-1.46%)
Aug 30, 2024, 4:25 PM CET
Hofseth BioCare ASA Company Description
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States.
The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein.
The company was incorporated in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA
![Hofseth BioCare ASA logo](https://img.stockanalysis.com/logos1/OL/HBC.png)
Country | Norway |
Founded | 2000 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 71 |
CEO | Jon Odegard |
Contact Details
Address: Keiser Wilhelms gate 24 Ålesund, 6003 Norway | |
Phone | 47 73 10 22 00 |
Website | hofsethbiocare.com |
Stock Details
Ticker Symbol | HBC |
Exchange | Oslo Børs |
Fiscal Year | January - December |
Reporting Currency | NOK |
ISIN Number | NO0010598683 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Jon Olav Odegard | Chief Executive Officer |
Christel Elise Kanli | Chief Financial Officer and Chief Operating Officer |
Dr. Bomi Framroze | Chief Scientific Officer |
James Berger | Chief Commercial Officer |
Angelika Florvaag | Chief Quality Officer |